Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Balaguer F, Castellví-Bel S, Castells A, Andreu M, Muñoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Balaguer F, et al. Among authors: andreu m. Clin Gastroenterol Hepatol. 2007 Mar;5(3):379-87. doi: 10.1016/j.cgh.2006.12.025. Clin Gastroenterol Hepatol. 2007. PMID: 17368238
Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study.
Piñol V, Andreu M, Castells A, Payá A, Bessa X, Rodrigo J; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: andreu m. Eur J Gastroenterol Hepatol. 2004 Jan;16(1):39-45. doi: 10.1097/00042737-200401000-00007. Eur J Gastroenterol Hepatol. 2004. PMID: 15095851
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: andreu m. JAMA. 2005 Apr 27;293(16):1986-94. doi: 10.1001/jama.293.16.1986. JAMA. 2005. PMID: 15855432
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Llor X, et al. Among authors: andreu m. Clin Cancer Res. 2005 Oct 15;11(20):7304-10. doi: 10.1158/1078-0432.CCR-05-0965. Clin Cancer Res. 2005. PMID: 16243801
Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
Castells A, Payá A, Alenda C, Rodríguez-Moranta F, Agrelo R, Andreu M, Piñol V, Castellví-Bel S, Jover R, Llor X, Pons E, Elizalde JI, Bessa X, Alcedo J, Saló J, Medina E, Naranjo A, Esteller M, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Castells A, et al. Among authors: andreu m. Clin Cancer Res. 2006 Mar 15;12(6):1686-92. doi: 10.1158/1078-0432.CCR-05-1581. Clin Cancer Res. 2006. PMID: 16551850
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Balaguer F, Cubiella J, Argüello L, Morillas JD, Bujanda L; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Rodríguez-Moranta F, et al. Among authors: andreu m. Am J Gastroenterol. 2006 May;101(5):1104-11. doi: 10.1111/j.1572-0241.2006.00522.x. Am J Gastroenterol. 2006. PMID: 16696788
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.
Castellví-Bel S, Castells A, de Cid R, Muñoz J, Balaguer F, Gonzalo V, Ruiz-Ponte C, Andreu M, Llor X, Jover R, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Carracedo A, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Castellví-Bel S, et al. Among authors: andreu m. Carcinogenesis. 2007 Aug;28(8):1687-91. doi: 10.1093/carcin/bgm098. Epub 2007 Apr 21. Carcinogenesis. 2007. PMID: 17449901
Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E, Llor X, Cordero C, Fernandez-Bañares F, de Castro L, Reñé JM, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Ballesté B, et al. Among authors: andreu m. Dis Colon Rectum. 2007 Jul;50(7):971-80. doi: 10.1007/s10350-007-0237-2. Dis Colon Rectum. 2007. PMID: 17468913
Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.
Balaguer F, Balmaña J, Castellví-Bel S, Steyerberg EW, Andreu M, Llor X, Jover R, Syngal S, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Balaguer F, et al. Among authors: andreu m. Gastroenterology. 2008 Jan;134(1):39-46. doi: 10.1053/j.gastro.2007.10.042. Epub 2007 Oct 26. Gastroenterology. 2008. PMID: 18061181 Free PMC article.
311 results